Kanawha Capital Management’s CVS Health CVS Stock Holding History

Kanawha Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,128	Closed	-$248K	–	223
2025 Q4	$248K	Sell	3,128 -550	-15%	-$43.4K	0.02%	202
2025 Q3	$277K	Buy	3,678 +550	+18%	+$37.7K	0.02%	195
2025 Q2	$216K	Buy	+3,128	New	+$205K	0.02%	212
2024 Q3	–	Sell	-26,130	Closed	-$1.54M	–	232
2024 Q2	$1.54M	Sell	26,130 -15,592	-37%	-$975K	0.12%	105
2024 Q1	$3.33M	Sell	41,722 -3,071	-7%	-$235K	0.27%	75
2023 Q4	$3.54M	Sell	44,793 -4,570	-9%	-$325K	0.32%	69
2023 Q3	$3.45M	Sell	49,363 -9,726	-16%	-$689K	0.33%	69
2023 Q2	$4.08M	Sell	59,089 -3,493	-6%	-$249K	0.38%	69
2023 Q1	$4.65M	Sell	62,582 -6,546	-9%	-$549K	0.45%	62
2022 Q4	$6.44M	Buy	69,128 +98	+0.1%	+$9.46K	0.63%	53
2022 Q3	$6.58M	Sell	69,030 -367	-0.5%	-$36.3K	0.72%	48
2022 Q2	$6.43M	Sell	69,397 -527	-0.8%	-$51.4K	0.65%	53
2022 Q1	$7.08M	Buy	69,924 +103	+0.1%	+$10.8K	0.62%	54
2021 Q4	$7.2M	Sell	69,821 -1,062	-1%	-$98.1K	0.61%	53
2021 Q3	$6.01M	Sell	70,883 -2,595	-4%	-$217K	0.56%	57
2021 Q2	$6.13M	Buy	73,478 +375	+0.5%	+$30.7K	0.56%	58
2021 Q1	$5.5M	Sell	73,103 -63	-0.1%	-$4.59K	0.54%	59
2020 Q4	$5M	Buy	73,166 +650	+0.9%	+$42.3K	0.51%	57
2020 Q3	$4.24M	Buy	72,516 +5,522	+8%	+$344K	0.49%	59
2020 Q2	$4.35M	Buy	66,994 +2,490	+4%	+$157K	0.54%	56
2020 Q1	$3.83M	Buy	64,504 +3,986	+7%	+$266K	0.56%	57
2019 Q4	$4.5M	Buy	60,518 +1,314	+2%	+$92.3K	0.52%	58
2019 Q3	$3.73M	Buy	59,204 +215	+0.4%	+$12.7K	0.49%	59
2019 Q2	$3.21M	Buy	58,989 +7,714	+15%	+$415K	0.43%	63
2019 Q1	$2.77M	Buy	51,275 +4,575	+10%	+$282K	0.39%	66
2018 Q4	$3.06M	Buy	46,700 +2,799	+6%	+$209K	0.48%	62
2018 Q3	$3.46M	Buy	43,901 +942	+2%	+$67.3K	0.48%	62
2018 Q2	$2.76M	Sell	42,959 -2,275	-5%	-$150K	0.41%	64
2018 Q1	$2.81M	Sell	45,234 -550	-1%	-$39.5K	0.43%	63
2017 Q4	$3.32M	Sell	45,784 -2,595	-5%	-$189K	0.49%	62
2017 Q3	$3.93M	Sell	48,379 -1,020	-2%	-$80.7K	0.6%	59
2017 Q2	$3.98M	Buy	49,399 +422	+0.9%	+$33.3K	0.62%	57
2017 Q1	$3.85M	Buy	48,977 +3,469	+8%	+$277K	0.61%	57
2016 Q4	$3.59M	Sell	45,508 -2,365	-5%	-$191K	0.6%	58
2016 Q3	$4.26M	Buy	47,873 +2,493	+5%	+$235K	0.71%	54
2016 Q2	$4.34M	Buy	45,380 +2,188	+5%	+$218K	0.73%	55
2016 Q1	$4.48M	Buy	43,192 +2,675	+7%	+$260K	0.77%	53
2015 Q4	$3.96M	Buy	40,517 +2,485	+7%	+$243K	0.71%	54
2015 Q3	$3.67M	Buy	38,032 +2,975	+8%	+$313K	0.71%	52
2015 Q2	$3.68M	Buy	35,057 +1,768	+5%	+$181K	0.65%	56
2015 Q1	$3.44M	Sell	33,289 -405	-1%	-$41K	0.6%	60
2014 Q4	$3.25M	Buy	33,694 +40	+0.1%	+$3.52K	0.57%	62
2014 Q3	$2.68M	Buy	33,654 +699	+2%	+$55.1K	0.49%	69
2014 Q2	$2.48M	Sell	32,955 -320	-1%	-$24.2K	0.46%	70
2014 Q1	$2.49M	Sell	33,275 -425	-1%	-$30K	0.47%	70
2013 Q4	$2.41M	Buy	33,700 +100	+0.3%	+$6.42K	0.46%	71
2013 Q3	$1.91M	Buy	33,600 +3,600	+12%	+$215K	0.39%	76
2013 Q2	$1.72M	Buy	+30,000	New	+$1.74M	0.38%	76

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kanawha Capital Management's CVS Position: Q1 2026 in Review

Kanawha Capital Management sold out of CVS Health (CVS) in Q1 2026, closing a stake of 3,128 shares — an estimated $248K sold.

Kanawha Capital Management first reported a position in CVS in Q2 2013 and held it in 48 quarters. The position peaked at $7.2M in Q4 2021. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Kanawha Capital Management reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
Kanawha Capital Management sold 3,128 CVS Health shares in Q1 2026, an estimated $248K.
Kanawha Capital Management first reported a position in CVS Health in Q2 2013 and held it in 48 quarters.
Kanawha Capital Management's CVS Health position peaked at $7.2M in Q4 2021.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Kanawha Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.